FIELD: chemistry.
SUBSTANCE: invention relates to field of biotechnology and deals with novel compounds, which possess antiangiogenic activity. The described invention represents peptide, which bounds endothelial cell growth factor (VEGF), as well as peptide, binding VEGF, conjugated with molecules of antibodies separately and in conjugated bond with other antiangiogenic molecules.
EFFECT: claimed solution can be used for inhibition or reduction of angiogenesis.
29 cl, 14 tbl, 17 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIANGIOGENIC COMPOUNDS | 2007 |
|
RU2418003C2 |
| SUBSTRATES OF MATRIX METALLOPROTEINASE AND OTHER CLEAVABLE MOIETIES AND METHODS FOR USE THEREOF | 2014 |
|
RU2715232C2 |
| ANTIBODY-DRUG CONJUGATES (ADC) WHICH BIND TO FLT3 PROTEINS | 2016 |
|
RU2739617C2 |
| INHIBITORS OF RECEPTORS OF TYPE 2 VESSEL ENDOTHELIUM GROWTH FACTOR | 2004 |
|
RU2402567C2 |
| PRODRUG COMPOSITIONS BASED ON CROSS-LINKED HYALURONIC ACID HYDROGEL AND METHODS OF THEIR PRODUCTION | 2018 |
|
RU2812787C2 |
| ANTI-FcRH5 ANTIBODIES | 2014 |
|
RU2687132C2 |
| STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF | 2016 |
|
RU2648152C2 |
| VEGF INHIBITING STABLE AND SOLUBLE ANTIBODIES | 2009 |
|
RU2531523C9 |
| THERAPEUTIC DLL4-BINDING PROTEINS | 2010 |
|
RU2570639C2 |
| STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF | 2009 |
|
RU2588467C2 |
